n-((5-Bromothiophen-2-yl)methyl)cyclopropanamine, 95%, 250mg

4,4'-Di(1H-imidazol-1-yl)-1,1'-biphenyl>98.0%(HPLC)(N)1g

(2-FLUORO-4-METHOXYPHENYL)BORONIC ACID PINACOL ESTER, 95.0%, 25g

2-bromo-4-isopropoxy-5-methoxybenzaldehyde, 95.0%, 1g

CGRGDS Peptide Hydrochloride>90.0%(HPLC)10mg

3-(4-Biphenyl)propionic acid, 98%, 1g

D-lysine hydrochloride min 99% for biochemistry 1g glass packaging

2-Naphthhydrazide, 98.0%, 1g

tert-Butyl (3-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)amino)propyl)carbamate, 250mg

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(3,4-dichlorophenyl)butanoic acid, 98%, 5g

TAZEMETOSTAT, 98%, 250mg

3-Amino-1-cyclopropyl-propan-1-ol, 95.0%, 250mg

3,5-dibromo-1-[(1,3-dioxolan-2-yl)methyl]-1H-1,2,4-triazole, 95.0%, 2g